Drug profile · INN
pasireotide pamoate
SIGNIFOR PARTIAL CHANGE APPROVAL
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pasireotide pamoate (SIGNIFOR PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient. Route of administration: intramuscular. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is pasireotide pamoate?
pasireotide pamoate (SIGNIFOR PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient. Route of administration: intramuscular. Current US regulatory status: approved.
What is the brand name for pasireotide pamoate?
SIGNIFOR PARTIAL CHANGE APPROVAL is a marketed brand name for pasireotide pamoate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pasireotide pamoate?
pasireotide pamoate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.